07/27/2026
The conversation around peptides continues to evolve, and we’ve received a lot of questions about whether Rejuvenate Health will be offering peptide therapies.
Our answer is simple:
We will always follow the law before following the trend.
At Rejuvenate Health, patient safety, ethical practice, and regulatory compliance are non-negotiable. While there is significant interest in peptides such as BPC-157, TB-500, KPV, MOTS-c, and others, many remain subject to FDA regulations and evolving guidance.
Rather than rushing to offer treatments simply because they’re popular, we have made the decision to wait until we can prescribe and dispense these therapies in a manner that is fully compliant with applicable federal and state laws and current FDA regulations.
Our commitment is to:
✔️ Practice evidence-based medicine
✔️ Work with reputable, licensed pharmacies
✔️ Follow all FDA and state regulatory requirements
✔️ Put patient safety above profits or trends
If and when peptide therapies can be offered legally and responsibly, we’ll be ready. Until then, we’ll continue providing treatments that meet the highest standards of safety, quality, and compliance.
Thank you for trusting Rejuvenate Health to always do what’s right—not just what’s popular.
